Literature DB >> 10958757

Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.

H Fakhrai-Rad1, A Nikoshkov, A Kamel, M Fernström, J R Zierath, S Norgren, H Luthman, J Galli.   

Abstract

Genetic analysis of the diabetic GK rat has revealed several diabetes susceptibility loci. Congenic strains have been established for the major diabetes locus, Niddm1, by transfer of GK alleles onto the genome of the normoglycemic F344 rat. Niddm1 was dissected into two subloci, physically separated in the congenic strains Niddm1b and Niddm1i, each with at least one disease susceptibility gene. Here we have mapped Niddm1b to 1 cM by genetic and pathophysiological characterization of new congenic substrains for the locus. The gene encoding insulin-degrading enzyme (IDE:) was located to this 1 cM region, and the two amino acid substitutions (H18R and A890V) identified in the GK allele reduced insulin-degrading activity by 31% in transfected cells. However, when the H18R and A890V variants were studied separately, no effects were observed, demonstrating a synergistic effect of the two variants on insulin degradation. No effect on insulin degradation was observed in cell lysates, indicating that the effect is coupled to receptor-mediated internalization of insulin. Congenic rats with the IDE: GK allele displayed post-prandial hyperglycemia, reduced lipogenesis in fat cells, blunted insulin-stimulated glucose transmembrane uptake and reduced insulin degradation in isolated muscle. Analysis of additional rat strains demonstrated that the dysfunctional IDE: allele was unique to GK. These data point to an important role for IDE: in the diabetic phenotype in GK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958757     DOI: 10.1093/hmg/9.14.2149

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  59 in total

1.  The diversity of histone versus nonhistone sirtuin substrates.

Authors:  Paloma Martínez-Redondo; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2013-03

2.  Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.

Authors:  Fengmin Li; Jian Yang; Van Anthony M Villar; Laureano D Asico; Xiaobo Ma; Ines Armando; Hironobu Sanada; Minoru Yoneda; Robin A Felder; Pedro A Jose; Xiaoyan Wang
Journal:  Diabetologia       Date:  2017-10-28       Impact factor: 10.122

3.  Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.

Authors:  Pablo Villa-Pérez; Beatriz Merino; Cristina M Fernández-Díaz; Pilar Cidad; Carmen D Lobatón; Alfredo Moreno; Harrison T Muturi; Hilda E Ghadieh; Sonia M Najjar; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Metabolism       Date:  2018-08-08       Impact factor: 8.694

4.  Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.

Authors:  J L Harenza; P P Muldoon; M De Biasi; M I Damaj; M F Miles
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

Review 5.  Type 2 diabetes: new genes, new understanding.

Authors:  Inga Prokopenko; Mark I McCarthy; Cecilia M Lindgren
Journal:  Trends Genet       Date:  2008-10-25       Impact factor: 11.639

6.  Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.

Authors:  Julie Charton; Marion Gauriot; Jane Totobenazara; Nathalie Hennuyer; Julie Dumont; Damien Bosc; Xavier Marechal; Jamal Elbakali; Adrien Herledan; Xiaoan Wen; Cyril Ronco; Helene Gras-Masse; Antoine Heninot; Virginie Pottiez; Valerie Landry; Bart Staels; Wenguang G Liang; Florence Leroux; Wei-Jen Tang; Benoit Deprez; Rebecca Deprez-Poulain
Journal:  Eur J Med Chem       Date:  2014-12-04       Impact factor: 6.514

7.  Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

Authors:  Christina Yfanti; Karin Mengele; Apostolos Gkazepis; Gregor Weirich; Cecylia Giersig; Wen-Liang Kuo; Wei-Jen Tang; Marsha Rosner; Manfred Schmitt
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

8.  A monomeric variant of insulin degrading enzyme (IDE) loses its regulatory properties.

Authors:  Eun Suk Song; David W Rodgers; Louis B Hersh
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

9.  Integration of the rat recombination and EST maps in the rat genomic sequence and comparative mapping analysis with the mouse genome.

Authors:  Steven P Wilder; Marie-Thérèse Bihoreau; Karène Argoud; Takeshi K Watanabe; Mark Lathrop; Dominique Gauguier
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

10.  Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme.

Authors:  Anthony Delledonne; Naomi Kouri; Lael Reinstatler; Tomoko Sahara; Lilin Li; Ji Zhao; Dennis W Dickson; Nilufer Ertekin-Taner; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-10-16       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.